Status:
RECRUITING
Intra-sheath vs Extra-sheath Injection for De Quervain's Tenosynovitis
Lead Sponsor:
University of California, Davis
Conditions:
De Quervain Tenosynovitis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The aim of the study is to determine whether or not extra-sheath steroid injections are inferior to intra-sheath steroid injections in the treatment of DeQuervain's Tenosynovitis. Patients will be ra...
Detailed Description
Null Hypothesis: Extra-sheath steroid injections are inferior to intra-sheath steroid injections in the treatment of DeQuervain's tenosynovitis. Alternative Hypothesis:Extra-sheath steroid injections...
Eligibility Criteria
Inclusion
- Signed informed consent from the patient exclusively and not a legal representative
- Clinically diagnosed with De Quervain's
- VAS score of at least 40mm pre-injection
- Life expectancy greater than 1 year
Exclusion
- Having previously undergone steroid injection in the treatment of De Quervain's
- Having previously undergone surgery for De Quervain's in the affected wrist
- Having previously undergone steroid injection and failed in the treatment of trigger finger
- Allergies to lidocaine or dexamethasone
- Underlying serious medical conditions that would place the patient at risk
- Past history of hypothyroidism or rheumatoid arthritis
- Pregnant women
- Prisoners
Key Trial Info
Start Date :
January 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04895956
Start Date
January 24 2022
End Date
June 1 2025
Last Update
March 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UC Davis Health, Department of Orthopaedics
Sacramento, California, United States, 95817